| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |